Document is current
Any future updates will be listed below
-
Authors
Sakellaris, Ioannis A.
Mandin, Corinne
Bright, Franziska
Orsi, Laurent
Amat, Flore
Bonnet, Pierre
Siroux, Valérie
Moual, Nicole Le
Dumas, Orianne
-
Funding
Funding for this research was provided by:
Fondation de France (00155204)
Fondation de France (00081167)
Anses (Anses-PNR-EST-2017-1-101)
Ademe (1762C0021)
ARS Ile de France (Grant 2018-2019)
ANR (ANR-18-CE36-0002; CRESMINA)
- License Information
-
More Information
Article History
Received: 14 January 2026
Accepted: 4 May 2026
First Online: 13 May 2026
Declarations
:
: The CRESPI study, sponsored by the French National Institute for Health and Medical Research (Inserm, references C18-05; ID RCB n° 2018-A02657-48), has been approved by the French ethics committee “Comité de protection des personnes” (CPP Sud - Est I n°2019-38; May 2019) and the French Data Protection Authority “Commission Nationale de l’Informatique et des Libertés” (CNIL n°919185; October 2019). The CRESPI protocol was registered in the clinical trials register (NCT n° 04170881).
: Not applicable.
: The authors declare no competing interests.
